Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Etsuko Yamamori"'
Autor:
Takeshi Onoue, Motomitsu Goto, Eri Wada, Mariko Furukawa, Takayuki Okuji, Norio Okada, Tomoko Kobayashi, Shintaro Iwama, Mariko Sugiyama, Taku Tsunekawa, Hiroshi Takagi, Daisuke Hagiwara, Yoshihiro Ito, Yoshiaki Morishita, Yusuke Seino, Hidetaka Suga, Ryoichi Banno, Yoji Hamada, Masahiko Ando, Etsuko Yamamori, Hiroshi Arima
Publikováno v:
PLoS ONE, Vol 15, Iss 1, p e0228004 (2020)
Type 2 diabetes and dyslipidemia are diseases that collectively increase the risk of patients developing cardiovascular complications. Several incretin-based drugs are reported to improve lipid metabolism, and one of these medications, anagliptin, is
Externí odkaz:
https://doaj.org/article/a43f16213948470f87db8dff1aa15896
Autor:
Yoshiharu Ozawa, Hideki Muramatsu, Etsuko Yamamori, Yuto Suzuki, Sosuke Arakawa, Kohei Fujita, Ayana Ishiguro, Makoto Nakao, Yusuke Sakai, Hidefumi Sato
Publikováno v:
JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE. 68:535-542
Autor:
Yusuke Seino, Eri Wada, Masahiko Ando, Mariko Furukawa, Norio Okada, Ryoichi Banno, Daisuke Hagiwara, Hiroshi Takagi, Shintaro Iwama, Taku Tsunekawa, Takayuki Okuji, Yoshiaki Morishita, Hiroshi Arima, Tomoko Kobayashi, Hidetaka Suga, Mariko Sugiyama, Motomitsu Goto, Yoji Hamada, Takeshi Onoue, Yoshihiro Ito, Etsuko Yamamori
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 1, p e0228004 (2020)
PLoS ONE, Vol 15, Iss 1, p e0228004 (2020)
Type 2 diabetes and dyslipidemia are diseases that collectively increase the risk of patients developing cardiovascular complications. Several incretin-based drugs are reported to improve lipid metabolism, and one of these medications, anagliptin, is
Autor:
Etsuko Yamamori, Kunikazu Kondo, Yuji Tanaka, Ayako Kakita, Yutaka Oiso, Hiroomi Funahashi, Nobuo Nakashima, Yasumasa Iwasaki, Noriko Mutsuga, Tsuneo Imai
Publikováno v:
Endocrine Journal. 50:545-551
We have developed a new test for estimating the secretory capacity of parathyroid hormone (PTH) from the parathyroid gland. Sodium bicarbonate solution [8.4% (w/v); 35 ml/m(2) body surface area] was infused for 2 min, and blood samples for the determ
Autor:
Atsushi Nomura, Masanori Yoshida, Yutaka Oiso, Etsuko Yamamori, Minako Morishita, Hisao Seo, Fukushi Kambe, Masato Asai, Hidehiko Saito, Yasumasa Iwasaki, Nobuaki Ozaki, Noriko Mutsuga
Publikováno v:
Molecular Endocrinology. 15:2149-2156
Although GHRH is known to play a pivotal role in the regulation of the GHRH-GH-IGF-I axis, the molecular mechanism of GHRH gene expression has not yet been examined. Here we studied the transcriptional regulation of the GHRH gene 5'promoter using an
Autor:
Masato Asai, Noriko Mutsuga, Minako Morishita, Y. Aoki, Yutaka Oiso, Yasumasa Iwasaki, H. Saito, K. Tachikawa, Masanori Yoshida, Y. Ariyoshi, Etsuko Yamamori, A. Nomura
Publikováno v:
Journal of Neuroendocrinology. 13:774-778
Polyamines are a ubiquitous group of amines that play diverse biological roles. In the anterior pituitary, intracellular polyamine levels are reported to show diurnal changes, although the biological significance remains to be elucidated. In this stu
Autor:
Etsuko Yamamori, Noriko Mutsuga, Yutaka Oiso, Atsushi Nomura, Yoshiaki Aoki, Hidehiko Saito, Masanori Yoshida, Yasumasa Iwasaki, Masato Asai
Publikováno v:
Neuroendocrinology. 74:87-94
Although opioid peptides are involved in the regulation of the hypothalamic-pituitary-adrenal axis, their role in pro-opiomelanocortin (POMC) gene expression at the pituitary level is not known. We therefore examined the effects of opioid receptor ag
Autor:
Yutaka Oki, Masato Asai, Yutaka Oiso, Yasumasa Iwasaki, Masanori Yoshida, Etsuko Yamamori, Machiko Kambayashii, Nobuo Nakashima
Publikováno v:
Endocrinology. 145:36-38
We examined the role of intracellular calcium release in the regulation of CRH-induced ACTH secretion using the AtT20 corticotroph cell line. We found that ruthenium red, an inhibitor of ryanodine receptor, substantially diminished the secretory resp
Autor:
Etsuko Yamamori, Yasumasa Iwasaki, Machiko Kambayashi, Masanori Yoshida, Takafumi Taguchi, Mitsuru Nishiyama, Yutaka Oiso, Masato Asai, Keiichi Itoi, Kozo Hashimoto
Publikováno v:
Molecular and cellular endocrinology. 264(1-2)
The molecular mechanisms for the suppression of corticotropin-releasing hormone (CRH) gene expression by glucocorticoid remain to be clarified albeit the well-known physiological role of the glucocorticoid-induced negative feedback regulation of the
Autor:
Yasumasa Iwasaki, Atsushi Nomura, Masanori Yoshida, Noriko Mutsuga, Yutaka Oiso, Masato Asai, Etsuko Yamamori, Hidehiko Saito, Minako Morishita
Publikováno v:
Endocrinology. 141(9)
The presence of high-affinity binding sites for antidiabetic sulfonylureas (SUs) and the expression of SU receptor (SUR) messenger RNA in the adenohypophyseal cells have recently been reported. In this study, we examined the effects of SU on POMC gen